Show simple item record

dc.contributor.authorVelagapudi, Venu
dc.contributor.authorBarton, Bruce A
dc.contributor.authorStoff, Jeffrey S.
dc.date2022-08-11T08:08:12.000
dc.date.accessioned2022-08-23T15:46:09Z
dc.date.available2022-08-23T15:46:09Z
dc.date.issued2011-05-20
dc.date.submitted2011-09-01
dc.identifier.doi10.13028/tdem-ca40
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27691
dc.description.abstractBackground: Hyperkalemia is common and lethal electrolyte disorder with little known long-term consequences. This was retrospective, observational study of hospitalized patients with initial serum K > 5.3 mEq/L. 143 consecutive episodes of hyperkalemia were analyzed in 133 patients. Survival was analyzed by parameters of renal dysfunction (admit eGFR), CHF, admit K and EKG abnormalities. Methods: Hazard ratios (HR) for mortality were computed by Cox proportional hazards multivariate regression. Primary end point, all-cause mortality determined by Social Security Death Index and medical record review. Results: Admit eGFR was the most powerful predictor of mortality. The effect of renal function was nonlinear(figure 1). Highest mortality is eGFR group of 15-59 HR 6.92. More severe renal impairment with eGFR(HD) HR 3.67. ESRD had lower mortality HR 1.33(table 1). Hyperkalemic severity had a modest effect(figure 2). Compared to patients Admit K 5.3-5.9 mEq/L, patients with K 6-7, HR 2.21 (p=0.0210) and K >7.0, HR 2.62 (p=0.0521). History of CHF, increased mortality by univariate analysis (p Conclusions: Survival in hyperkalemic patients is predicted by lower admit eGFR in a non-linear fashion. ESRD patients exhibited lower mortality perhaps reflecting adaptation to chronic hyperkalemia. CHF has an additive effect on mortality in non HD patients. We emphasize that 86% of the mortality was after discharge. This extraordinary mortality necessitates the need to develop risk stratification strategies in the long-term care of the hyperkalemic patients.
dc.formatyoutube
dc.language.isoen_US
dc.rightsCopyright the Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectClinical Epidemiology
dc.subjectNutritional and Metabolic Diseases
dc.titleOutcome of Hyperkalemia in the Emergency Department: Impact of Hyperkalemic Severity, Renal Function and CHF on Survival
dc.typePoster Abstract
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1022&context=cts_retreat&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cts_retreat/2011/posters/12
dc.identifier.contextkey2211284
refterms.dateFOA2022-08-23T15:46:09Z
html.description.abstract<p><strong>Background:</strong> Hyperkalemia is common and lethal electrolyte disorder with little known long-term consequences. This was retrospective, observational study of hospitalized patients with initial serum K > 5.3 mEq/L. 143 consecutive episodes of hyperkalemia were analyzed in 133 patients. Survival was analyzed by parameters of renal dysfunction (admit eGFR), CHF, admit K and EKG abnormalities.</p> <p><strong>Methods:</strong> Hazard ratios (HR) for mortality were computed by Cox proportional hazards multivariate regression. Primary end point, all-cause mortality determined by Social Security Death Index and medical record review. <strong></strong></p> <p><strong>Results:</strong> Admit eGFR was the most powerful predictor of mortality. The effect of renal function was nonlinear(figure 1). Highest mortality is eGFR group of 15-59 HR 6.92. More severe renal impairment with eGFR(HD) HR 3.67. ESRD had lower mortality HR 1.33(table 1). Hyperkalemic severity had a modest effect(figure 2). Compared to patients Admit K 5.3-5.9 mEq/L, patients with K 6-7, HR 2.21 (p=0.0210) and K >7.0, HR 2.62 (p=0.0521). History of CHF, increased mortality by univariate analysis (p</p> <p><strong>Conclusions:</strong> Survival in hyperkalemic patients is predicted by lower admit eGFR in a non-linear fashion. ESRD patients exhibited lower mortality perhaps reflecting adaptation to chronic hyperkalemia. CHF has an additive effect on mortality in non HD patients. We emphasize that 86% of the mortality was after discharge. This extraordinary mortality necessitates the need to develop risk stratification strategies in the long-term care of the hyperkalemic patients.</p>
dc.identifier.submissionpathcts_retreat/2011/posters/12


Files in this item

Thumbnail
Name:
Velagapudi_archivesUMassK.pdf
Size:
192.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright the Author(s)
Except where otherwise noted, this item's license is described as Copyright the Author(s)